No Clinically Significant Interaction Between Tizanidine and Carafate (Sucralfate)
There is no documented clinically significant drug interaction between tizanidine and sucralfate (Carafate), though sucralfate may theoretically reduce tizanidine absorption if taken simultaneously.
Key Interaction Considerations
Sucralfate's General Interaction Profile
Sucralfate works by forming a protective barrier in the gastrointestinal tract and can bind to various medications, reducing their absorption 1. The FDA label for Carafate explicitly states that it can reduce bioavailability of multiple drugs through non-systemic binding in the GI tract 1. A comprehensive review confirms sucralfate causes malabsorption of many medications by chelating drugs within the GI lumen 2.
The critical management strategy: administer other drugs at least 2 hours before sucralfate or 4-6 hours after to avoid potential binding interactions 1.
Tizanidine's Interaction Profile
The primary concern with tizanidine involves CYP1A2 inhibitors, not GI binding agents 3. The FDA label for tizanidine and multiple guidelines emphasize that:
- Contraindicated combinations: ciprofloxacin and fluvoxamine (significantly reduce tizanidine clearance) 3, 4
- Significant interactions: other CYP1A2 inhibitors like oral contraceptives, cimetidine, famotidine, verapamil cause hypotension, bradycardia, and excessive sedation 3, 4
- A disproportionality analysis found serious adverse events (hypotension, falls, fractures) with CYP1A2 inhibitors, particularly ciprofloxacin and fluvoxamine 5
Why This Combination Is Likely Safe
Neither the FDA labels for tizanidine 4 nor sucralfate 1 mention each other as interacting drugs. The extensive literature on both medications does not identify this as a problematic combination. Tizanidine's narrow therapeutic index and high interpatient variability 6 make it sensitive to metabolic interactions, but sucralfate does not affect CYP1A2 metabolism.
Practical Management Recommendations
Dosing Strategy
- Separate administration by at least 2 hours to minimize any theoretical absorption interference
- Give tizanidine first, then sucralfate 2+ hours later, OR
- Give sucralfate, wait 4-6 hours, then give tizanidine
Monitoring Parameters
- Monitor for tizanidine's expected adverse effects: sedation, drowsiness, dizziness, dry mouth, hypotension 3, 4
- These effects are dose-dependent and related to plasma concentrations 6
- Watch for orthostatic hypotension, particularly in elderly patients or those with renal impairment 4
Important Caveats
Special populations requiring extra caution:
- Renal impairment (CrCl <25 mL/min): Tizanidine clearance reduced >50%; reduce individual doses 4
- Women on oral contraceptives: Tizanidine clearance reduced ~50%; reduce individual doses 4
- Elderly patients: Tizanidine clearance decreased 4-fold; use with caution 4
Do not abruptly discontinue tizanidine - risk of rebound hypertension, tachycardia, and hypertonia 3, 4. Taper slowly if discontinuation needed.
Avoid These Actual Dangerous Combinations
With tizanidine:
- Ciprofloxacin or fluvoxamine (contraindicated) 3, 4
- Other CYP1A2 inhibitors without dose adjustment 3
- Alcohol (additive CNS depression, increased tizanidine levels) 4
With sucralfate:
- Warfarin requires careful monitoring - case reports show doubling of warfarin requirements even with 12-hour separation 7
- Fluoroquinolones show significant bioavailability loss 2
Bottom Line
The tizanidine-sucralfate combination can be used safely with appropriate dose separation. Focus monitoring on tizanidine's known adverse effects rather than worrying about this specific interaction. The real dangers with tizanidine involve CYP1A2 inhibitors, not GI binding agents like sucralfate.